Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation

Alex Shimura Yamashita1, Murilo Vieira Geraldo, Cesar Seigi Fuziwara

  • 1Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, Sã Paulo, Brazil.

Insights

Mitogen-activated protein kinase (MAPK) pathway activation drives papillary thyroid cancer (PTC) by upregulating Notch signaling. Inhibiting Notch or MAPK pathways suppressed PTC cell growth, suggesting Notch as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Papillary thyroid carcinomas (PTCs) frequently exhibit activated mitogen-activated protein kinase (MAPK) signaling due to genetic alterations in RET, RAS, or BRAF.
  • The impact of MAPK pathway activation on other oncogenic pathways, like Notch signaling, in PTC remains largely uncharacterized.

Purpose of the Study:

  • To investigate if the MAPK pathway regulates Notch signaling in PTC.
  • To determine the role of Notch signaling in PTC cell proliferation.

Main Methods:

  • Conditional induction of MAPK signaling oncogenes (RET/PTC3, BRAF(T1799A)) in rat thyroid cells.
  • Pharmacological inhibition of MAPK and Notch signaling (using γ-secretase inhibitor - GSI).
  • Analysis of Notch1 and Hes1 expression in cell lines and tumor samples; assessment of PTC cell proliferation.

Main Results:

  • MAPK activation (RET/PTC3, BRAF(T1799A)) led to increased Notch signaling, evidenced by elevated Notch1 receptor and Hes1 expression.
  • MAPK inhibition reduced Notch signaling in PTC cells.
  • High Notch1 expression was observed in BRAF(T1799A) transgenic mouse tumors and human PTC samples.
  • Down-regulating Notch signaling (via GSI or NOTCH1 RNA interference) decreased PTC cell proliferation.
  • Combined GSI and MAPK inhibition synergistically suppressed PTC cell growth.

Conclusions:

  • RET/PTC and BRAF(T1799A) oncogenes activate Notch signaling, contributing to thyroid follicular cell tumor growth.
  • Notch signaling represents a potential therapeutic target for adjuvant therapy in papillary thyroid cancer.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...